Zimmer Biomet Holdings Inc (ZBH) Position Lessened by Cohen & Steers Inc.

Cohen & Steers Inc. cut its holdings in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 47.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,887 shares of the medical equipment provider’s stock after selling 71,605 shares during the quarter. Cohen & Steers Inc.’s holdings in Zimmer Biomet were worth $9,237,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Bronfman E.L. Rothschild L.P. grew its stake in shares of Zimmer Biomet by 25.3% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after purchasing an additional 167 shares during the last quarter. FNY Managed Accounts LLC bought a new stake in shares of Zimmer Biomet in the third quarter worth about $117,000. BB&T Investment Services Inc. purchased a new stake in Zimmer Biomet in the second quarter worth about $144,000. Sandy Spring Bank lifted its holdings in Zimmer Biomet by 5.4% in the second quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock worth $166,000 after buying an additional 66 shares during the period. Finally, Penserra Capital Management LLC lifted its holdings in Zimmer Biomet by 13.0% in the second quarter. Penserra Capital Management LLC now owns 1,456 shares of the medical equipment provider’s stock worth $186,000 after buying an additional 168 shares during the period. 86.24% of the stock is currently owned by institutional investors.

Several analysts have commented on ZBH shares. Oppenheimer set a $137.00 price objective on shares of Zimmer Biomet and gave the stock a “buy” rating in a report on Monday, August 14th. Gabelli started coverage on shares of Zimmer Biomet in a report on Thursday, August 24th. They issued a “buy” rating and a $142.00 price objective for the company. Zacks Investment Research upgraded shares of Zimmer Biomet from a “sell” rating to a “hold” rating in a report on Tuesday, September 26th. SunTrust Banks restated a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet in a report on Monday, October 2nd. Finally, Piper Jaffray Companies lowered shares of Zimmer Biomet from an “overweight” rating to a “neutral” rating in a report on Thursday, November 2nd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $133.71.

Zimmer Biomet Holdings Inc (ZBH) traded down $1.40 during mid-day trading on Monday, hitting $113.38. 1,680,500 shares of the stock traded hands, compared to its average volume of 1,356,293. Zimmer Biomet Holdings Inc has a 1 year low of $100.81 and a 1 year high of $133.49. The stock has a market capitalization of $22,956.40, a price-to-earnings ratio of 14.05, a price-to-earnings-growth ratio of 1.76 and a beta of 1.15. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.88.

Zimmer Biomet (NYSE:ZBH) last released its earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet had a net margin of 8.36% and a return on equity of 16.29%. The business had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the previous year, the business posted $1.79 earnings per share. Zimmer Biomet’s revenue for the quarter was down .8% on a year-over-year basis. analysts forecast that Zimmer Biomet Holdings Inc will post 8.03 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Zimmer Biomet Holdings Inc (ZBH) Position Lessened by Cohen & Steers Inc.” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/11/zimmer-biomet-holdings-inc-zbh-position-lessened-by-cohen-steers-inc.html.

Zimmer Biomet Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply